Notable Labs Return on Tangible Equity 2013-2024 | NTBLQ
Current and historical return on tangible equity values for Notable Labs (NTBLQ) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Notable Labs Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2024-06-30 |
$-0.01B |
$0.01B |
-76.92% |
| 2024-03-31 |
$-0.01B |
$0.01B |
-50.00% |
| 2023-12-31 |
$-0.01B |
$0.02B |
-55.56% |
| 2023-09-30 |
$0.01B |
$0.02B |
100.00% |
| 2023-06-30 |
$-0.00B |
$0.02B |
-44.44% |
| 2023-03-31 |
$-0.01B |
$0.02B |
-85.71% |
| 2022-12-31 |
$-0.01B |
$-0.04B |
-80.00% |
| 2022-09-30 |
$-0.04B |
$0.03B |
-96.73% |
| 2022-06-30 |
$-0.04B |
$0.03B |
-79.10% |
| 2022-03-31 |
$-0.03B |
$0.04B |
-69.04% |
| 2021-12-31 |
$-0.03B |
$0.05B |
-63.16% |
| 2021-09-30 |
$-0.03B |
$0.05B |
-65.88% |
| 2021-06-30 |
$-0.03B |
$0.05B |
-68.35% |
| 2021-03-31 |
$-0.03B |
$0.04B |
-68.03% |
| 2020-12-31 |
$-0.02B |
$0.03B |
-67.61% |
| 2020-09-30 |
$-0.02B |
$0.04B |
-62.59% |
| 2020-06-30 |
$-0.02B |
$0.04B |
-58.28% |
| 2020-03-31 |
$-0.02B |
$0.03B |
-54.90% |
| 2019-12-31 |
$-0.02B |
$0.04B |
-46.51% |
| 2019-09-30 |
$-0.02B |
$0.04B |
-38.10% |
| 2019-06-30 |
$-0.02B |
$0.05B |
-35.12% |
| 2019-03-31 |
$-0.02B |
$0.05B |
-30.77% |
| 2018-12-31 |
$-0.02B |
$0.05B |
-36.20% |
| 2018-09-30 |
$-0.01B |
$0.06B |
-17.86% |
| 2018-06-30 |
$-0.01B |
$0.06B |
-24.37% |
| 2018-03-31 |
$-0.01B |
$0.05B |
-30.41% |
| 2017-12-31 |
$-0.01B |
$0.06B |
-27.67% |
| 2017-09-30 |
$-0.02B |
$0.03B |
-60.69% |
| 2017-06-30 |
$-0.02B |
$0.04B |
-44.44% |
| 2017-03-31 |
$-0.02B |
$0.04B |
-36.36% |
| 2016-12-31 |
$-0.02B |
$0.04B |
-37.87% |
| 2016-09-30 |
$-0.01B |
$0.05B |
-34.57% |
| 2016-06-30 |
$-0.02B |
$0.05B |
-48.92% |
| 2016-03-31 |
$-0.02B |
$0.03B |
-56.67% |
| 2015-12-31 |
$-0.02B |
$0.04B |
-49.59% |
| 2015-09-30 |
$-0.02B |
$0.02B |
-56.20% |
| 2015-06-30 |
$-0.02B |
$0.03B |
-60.00% |
| 2015-03-31 |
$-0.02B |
$0.03B |
-91.43% |
| 2014-12-31 |
$-0.02B |
$0.04B |
-189.47% |
| 2014-06-30 |
$-0.01B |
|
233.33% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.000B |
|
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
|
